Market research

CMRAW CMRAW

NASDAQ USD Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts

P/E ratio: Not available
Analyst target: Not available
Dividend yield: Not available
Beta: 0.39
MarketCapitalization: Not available

Loading price history…

Profile

Company facts

Exchange: NASDAQ
Currency: USD
Sector: Healthcare
Industry: Biotechnology
ISIN: Not available
P/E ratio: Not available
Analyst target: Not available
Dividend yield: Not available
Beta: 0.39
MarketCapitalization: Not available

About

About CMRAW

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. The company's lead pipeline candidate is CLS-001, a subcutaneous formulation of vedolizumab for the treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

Visit company website

Fundamentals are not available

This instrument does not currently have reported company financials in PyInvesting.

No comments yet

Start a focused discussion about CMRAW.

CMRAW CMRAW

Price & volume

Company facts

About CMRAW

Fundamentals are not available

Investor discussion

No comments yet